iTonic Holdings Ltd. (ITOC) vs Nephros, Inc. (NEPH)
A side-by-side comparison of iTonic Holdings Ltd. and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ITOC
iTonic Holdings Ltd.
$3.91HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
NEPH
Nephros, Inc.
$3.68HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
Total return — ITOC vs NEPH
growth of $100 · dividends reinvested · last 1yITOC -42.6% (-42.6%/yr)NEPH -29.4% (-29.4%/yr)NEPH compounded faster over this window
ITOC NEPH
ITOC vs NEPH: by the numbers
- •NEPH is the larger company ($40M vs $27M market cap).
- •NEPH is profitable (8.38% net margin) while ITOC runs a net loss (-974.68%).
Metrics side by side
Valuation
| Metric | ITOC | NEPH |
|---|---|---|
| P/E ratio | N/A | 23.19 |
| Forward P/E | N/A | 23.49 |
| P/S ratio | N/A | 1.93 |
| P/B ratio | 1.13 | 3.34 |
| EV / EBITDA | N/A | 20.47 |
Profitability
| Metric | ITOC | NEPH |
|---|---|---|
| Gross margin | 62.59% | 60.31% |
| Operating margin | -991.71% | 7.92% |
| Net margin | -974.68% | 8.38% |
| ROE | -83.26% | 14.51% |
| ROIC | -59.10% | 12.67% |
Growth (annualized)
| Metric | ITOC | NEPH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.99% |
| Total return CAGR (5Y) | N/A | -15.93% |
Frequently asked
- Is ITOC or NEPH more profitable?
- NEPH runs the higher net margin — ITOC at -974.68% versus NEPH at 8.38%.
Go deeper
Dig into the metrics
Nephros P/E ratioiTonic ROENephros ROEiTonic operating marginNephros operating marginiTonic revenue growthNephros revenue growthiTonic free cash flowNephros free cash flow
iTonic & Nephros appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.